Cargando…

Circulating levels of free 25(OH)D increase at the onset of rheumatoid arthritis

OBJECTIVE: Epidemiological studies suggest vitamin D deficiency as a potential risk factor for rheumatoid arthritis (RA) development, a chronic autoimmune disorder highly prevalent in indigenous North American (INA) population. We therefore profiled the circulating levels of 25-hydroxyvitaminD [25(O...

Descripción completa

Detalles Bibliográficos
Autores principales: Anaparti, Vidyanand, Meng, Xiaobo, Hemshekhar, Mahadevappa, Smolik, Irene, Mookherjee, Neeloffer, El-Gabalawy, Hani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6763124/
https://www.ncbi.nlm.nih.gov/pubmed/31557191
http://dx.doi.org/10.1371/journal.pone.0219109
_version_ 1783454171903557632
author Anaparti, Vidyanand
Meng, Xiaobo
Hemshekhar, Mahadevappa
Smolik, Irene
Mookherjee, Neeloffer
El-Gabalawy, Hani
author_facet Anaparti, Vidyanand
Meng, Xiaobo
Hemshekhar, Mahadevappa
Smolik, Irene
Mookherjee, Neeloffer
El-Gabalawy, Hani
author_sort Anaparti, Vidyanand
collection PubMed
description OBJECTIVE: Epidemiological studies suggest vitamin D deficiency as a potential risk factor for rheumatoid arthritis (RA) development, a chronic autoimmune disorder highly prevalent in indigenous North American (INA) population. We therefore profiled the circulating levels of 25-hydroxyvitaminD [25(OH)D], an active metabolite of vitamin D, in a cohort of at-risk first-degree relatives (FDR) of INA RA patients, a subset of whom subsequently developed RA (progressors). METHODS: 2007 onward, serum samples from INA RA patients and FDR were collected at the time of a structured baseline visit and stored at -20°C. Anti-citrullinated protein antibodies (ACPA), 25(OH)D, hs-CRP, vitamin-D binding protein (VDBP) and parathyroid hormone (PTH) levels were determined using ELISA and rheumatoid factor (RF) seropositivity was determined by nephelometry. RESULTS: We demonstrate that 25 (OH) D concentrations were lower in winter than summer (P = 0.0538), and that serum 25(OH)D levels were higher in samples collected and stored after 2013 (P<0.0001). Analysis of samples obtained after 2013 demonstrated that 37.6% of study participants were 25(OH)D insufficient (<75nmol/L). Also, seropositive RA patients and FDR had lower 25(OH)D levels compared to ACPA-/FDR (P<0.05, P<0.01 respectively). Linear regression analysis showed 25(OH)D insufficiency was inversely associated with presence of RA autoantibodies. Longitudinal samples from 14 progressors demonstrated a consistent increase in 25(OH)D levels at the time they exhibited clinically detectable joint inflammation, without any significant change in VDBP or PTH levels. Spearman rank correlation analysis showed significant association between 25(OH)D and PTH levels, both in RA patients and progressors at RA onset time. CONCLUSION: We demonstrate that 25(OH)D levels in serum increased at RA onset in progressors. The potential role that vitamin D metabolites and their downstream effects play in RA transition requires further investigation.
format Online
Article
Text
id pubmed-6763124
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-67631242019-10-12 Circulating levels of free 25(OH)D increase at the onset of rheumatoid arthritis Anaparti, Vidyanand Meng, Xiaobo Hemshekhar, Mahadevappa Smolik, Irene Mookherjee, Neeloffer El-Gabalawy, Hani PLoS One Research Article OBJECTIVE: Epidemiological studies suggest vitamin D deficiency as a potential risk factor for rheumatoid arthritis (RA) development, a chronic autoimmune disorder highly prevalent in indigenous North American (INA) population. We therefore profiled the circulating levels of 25-hydroxyvitaminD [25(OH)D], an active metabolite of vitamin D, in a cohort of at-risk first-degree relatives (FDR) of INA RA patients, a subset of whom subsequently developed RA (progressors). METHODS: 2007 onward, serum samples from INA RA patients and FDR were collected at the time of a structured baseline visit and stored at -20°C. Anti-citrullinated protein antibodies (ACPA), 25(OH)D, hs-CRP, vitamin-D binding protein (VDBP) and parathyroid hormone (PTH) levels were determined using ELISA and rheumatoid factor (RF) seropositivity was determined by nephelometry. RESULTS: We demonstrate that 25 (OH) D concentrations were lower in winter than summer (P = 0.0538), and that serum 25(OH)D levels were higher in samples collected and stored after 2013 (P<0.0001). Analysis of samples obtained after 2013 demonstrated that 37.6% of study participants were 25(OH)D insufficient (<75nmol/L). Also, seropositive RA patients and FDR had lower 25(OH)D levels compared to ACPA-/FDR (P<0.05, P<0.01 respectively). Linear regression analysis showed 25(OH)D insufficiency was inversely associated with presence of RA autoantibodies. Longitudinal samples from 14 progressors demonstrated a consistent increase in 25(OH)D levels at the time they exhibited clinically detectable joint inflammation, without any significant change in VDBP or PTH levels. Spearman rank correlation analysis showed significant association between 25(OH)D and PTH levels, both in RA patients and progressors at RA onset time. CONCLUSION: We demonstrate that 25(OH)D levels in serum increased at RA onset in progressors. The potential role that vitamin D metabolites and their downstream effects play in RA transition requires further investigation. Public Library of Science 2019-09-26 /pmc/articles/PMC6763124/ /pubmed/31557191 http://dx.doi.org/10.1371/journal.pone.0219109 Text en © 2019 Anaparti et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Anaparti, Vidyanand
Meng, Xiaobo
Hemshekhar, Mahadevappa
Smolik, Irene
Mookherjee, Neeloffer
El-Gabalawy, Hani
Circulating levels of free 25(OH)D increase at the onset of rheumatoid arthritis
title Circulating levels of free 25(OH)D increase at the onset of rheumatoid arthritis
title_full Circulating levels of free 25(OH)D increase at the onset of rheumatoid arthritis
title_fullStr Circulating levels of free 25(OH)D increase at the onset of rheumatoid arthritis
title_full_unstemmed Circulating levels of free 25(OH)D increase at the onset of rheumatoid arthritis
title_short Circulating levels of free 25(OH)D increase at the onset of rheumatoid arthritis
title_sort circulating levels of free 25(oh)d increase at the onset of rheumatoid arthritis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6763124/
https://www.ncbi.nlm.nih.gov/pubmed/31557191
http://dx.doi.org/10.1371/journal.pone.0219109
work_keys_str_mv AT anapartividyanand circulatinglevelsoffree25ohdincreaseattheonsetofrheumatoidarthritis
AT mengxiaobo circulatinglevelsoffree25ohdincreaseattheonsetofrheumatoidarthritis
AT hemshekharmahadevappa circulatinglevelsoffree25ohdincreaseattheonsetofrheumatoidarthritis
AT smolikirene circulatinglevelsoffree25ohdincreaseattheonsetofrheumatoidarthritis
AT mookherjeeneeloffer circulatinglevelsoffree25ohdincreaseattheonsetofrheumatoidarthritis
AT elgabalawyhani circulatinglevelsoffree25ohdincreaseattheonsetofrheumatoidarthritis